Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$76.51 USD
+3.01 (4.10%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $76.74 +0.23 (0.30%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 101 - 120 ( 529 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Takeaways From our KOL Call on Vaccines and Therapies Targeting COVID-19
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Does Smoke from CD47 Program at SITC Signal Further Flames at ASH?
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department